Related Experiment Videos
p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth
M Bonfanti1, S Taverna, M Salmona
1Molecular Pharmacology Unit, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Abstract:
We tested the ability of synthetic peptides derived from p21(WAF1), fused to the internalization peptide sequence derived from Antennapedia, to inhibit the growth of cancer cells in two human ovarian cancer cell lines expressing wild-type p53 or not. Two fused peptides corresponding to p21(WAF1) regions 17-33 and 63-77 inhibited cell growth in both cell lines while the same peptides without the internalization sequence were inactive. The fused peptides prevented growth at concentrations which inhibited cyclin-dependent kinase 2 and cdc2 activity, thus demonstrating that the peptides act by mimicking the action of p21(WAF1) on kinases. This study illustrates the potential pharmacological use of small peptides fused with the Antennapedia internalization sequence in proliferative disorders. The approach may be extended to other diseases in which cell penetration of a peptide may be of therapeutic benefit. More stable drug-like molecules with better pharmacological properties could be designed based on the results obtained with peptides.
Insights
Synthetic peptides targeting cancer cell growth show promise. Fusing p21(WAF1) peptides with Antennapedia internalization sequences effectively inhibited ovarian cancer cell proliferation by targeting key kinases.
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Discovery
Background:
- p21(WAF1) is a key regulator of cell cycle progression.
- Cancer cell proliferation is a hallmark of many diseases.
- Targeting cell cycle kinases is a common cancer therapy strategy.
Purpose of the Study:
- To evaluate the efficacy of synthetic peptides derived from p21(WAF1) fused to an internalization sequence in inhibiting cancer cell growth.
- To investigate the mechanism of action of these fused peptides on cell cycle kinases.
Main Methods:
- Synthesis of peptides derived from p21(WAF1) regions 17-33 and 63-77, fused to the Antennapedia internalization sequence.
- Testing peptide efficacy on human ovarian cancer cell lines with wild-type or mutated p53.
- Assessing inhibition of cyclin-dependent kinase 2 (CDK2) and cdc2 activity.
Main Results:
- Two fused peptides (p21(WAF1) 17-33 and 63-77) significantly inhibited cancer cell growth in both cell lines.
- Peptides without the internalization sequence were inactive, highlighting the importance of cell penetration.
- Inhibited cell growth correlated with decreased CDK2 and cdc2 activity, indicating kinase inhibition.
Conclusions:
- Synthetic peptides fused with the Antennapedia internalization sequence demonstrate potential for inhibiting cancer cell proliferation.
- These peptides mimic p21(WAF1)'s action on kinases, offering a novel therapeutic approach.
- The strategy may be applicable to other diseases requiring enhanced peptide cell penetration for therapeutic benefit.